Clinical Images: Severe interstitial lung disease in Sjögren disease - What happens in the lungs? Inflammation or fibrosis?
作者信息
Hoffmann Tobias, Gassler Nikolaus, Teichgräber Ulf, Sandhaus Tim, Oelzner Peter, Wolf Gunter, Pfeil Alexander
机构信息
Jena University Hospital Friedrich-Schiller-University, Jena, Germany.
出版信息
ACR Open Rheumatol. 2023 Feb;5(2):61-62. doi: 10.1002/acr2.11516. Epub 2022 Dec 15.
Abstract
摘要
相似文献
1
Clinical Images: Severe interstitial lung disease in Sjögren disease - What happens in the lungs? Inflammation or fibrosis?
ACR Open Rheumatol. 2023 Feb;5(2):61-62. doi: 10.1002/acr2.11516. Epub 2022 Dec 15.
2
Diffuse Cystic Lung Disease as the Presenting Manifestation of Sjögren Syndrome.
Ann Am Thorac Soc. 2016 Mar;13(3):371-5. doi: 10.1513/AnnalsATS.201511-759BC.
3
Lymphocytic Interstitial Pneumonia Associated with Sjögren Syndrome: Case-Based Review.
Curr Rheumatol Rev. 2023;19(1):1-6. doi: 10.2174/1573397118666220817091520.
4
[Severe pulmonary fibrosis disclosing primary Gougerot-Sjögren syndrome. Apropos of 5 cases, 2 of which were fatal].
Ann Med Interne (Paris). 1986;137(1):46-50.
5
Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
Natl Toxicol Program Tech Rep Ser. 2001 Jul(499):7-340.
6
Targeted nanotherapy with everolimus reduces inflammation and fibrosis in scleroderma-related interstitial lung disease developed by PSGL-1 deficient mice.
Br J Pharmacol. 2022 Sep;179(18):4534-4548. doi: 10.1111/bph.15898. Epub 2022 Jul 13.
7
Pulmonary Involvement in Sjögren Syndrome.
Clin Chest Med. 2019 Sep;40(3):531-544. doi: 10.1016/j.ccm.2019.05.002. Epub 2019 Jul 6.
8
[Comparative profile of antinuclear antibodies in Gougerot-Sjögren syndrome with and without diffuse interstitial pulmonary fibrosis].
Rev Rhum Mal Osteoartic. 1986 Nov;53(11):615-9.
9
NTP Toxicology and Carcinogenesis Studies of Nickel Subsulfide (CAS No. 12035-72-2) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
Natl Toxicol Program Tech Rep Ser. 1996 Jul;453:1-365.
10
FK506-Binding Protein 13 Expression Is Upregulated in Interstitial Lung Disease and Correlated with Clinical Severity. A Potentially Protective Role.
Am J Respir Cell Mol Biol. 2021 Feb;64(2):235-246. doi: 10.1165/rcmb.2020-0121OC.
引用本文的文献
1
Artificial intelligence-based quantification of pulmonary HRCT (AIqpHRCT) for the evaluation of interstitial lung disease in patients with inflammatory rheumatic diseases.
Rheumatol Int. 2024 Nov;44(11):2483-2496. doi: 10.1007/s00296-024-05715-0. Epub 2024 Sep 9.
2
Correlation of high-resolution computed tomography and immunological bronchoalveolar lavage in interstitial lung disease at the onset of inflammatory rheumatic diseases: implications for diagnosis and therapeutic strategies.
Arthritis Res Ther. 2024 Jul 29;26(1):142. doi: 10.1186/s13075-024-03371-0.
3
[Is JAK inhibition an option in the treatment of interstitial lung disease in rheumatoid arthritis?].
Z Rheumatol. 2024 Aug;83(6):495-499. doi: 10.1007/s00393-023-01434-2. Epub 2023 Oct 17.
本文引用的文献
1
Assessing the diagnostic value of a potential screening tool for detecting early interstitial lung disease at the onset of inflammatory rheumatic diseases.
Arthritis Res Ther. 2022 May 12;24(1):107. doi: 10.1186/s13075-022-02786-x.
2
Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial.
Arthritis Rheumatol. 2022 Jun;74(6):1039-1047. doi: 10.1002/art.42075. Epub 2022 May 2.
3
Organ Manifestation and Systematic Organ Screening at the Onset of Inflammatory Rheumatic Diseases.
Diagnostics (Basel). 2021 Dec 29;12(1):67. doi: 10.3390/diagnostics12010067.
4
Interstitial lung disease in Sjögren's syndrome: a clinical review.
Clin Exp Rheumatol. 2020 Jul-Aug;38 Suppl 126(4):291-300. Epub 2020 Oct 23.
5
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
N Engl J Med. 2019 Jun 27;380(26):2518-2528. doi: 10.1056/NEJMoa1903076. Epub 2019 May 20.
6
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.
7
Features of usual interstitial pneumonia in patients with primary Sjögren׳s syndrome compared with idiopathic pulmonary fibrosis.
Respir Investig. 2014 Jul;52(4):227-35. doi: 10.1016/j.resinv.2014.02.003. Epub 2014 Apr 13.
8
Localized expression of tenascin in systemic sclerosis-associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3.
Arthritis Rheum. 2012 Jan;64(1):272-80. doi: 10.1002/art.30647.
9
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL.
10
The impact of rheumatological evaluation in the management of patients with interstitial lung disease.
Rheumatology (Oxford). 2011 Mar;50(3):489-93. doi: 10.1093/rheumatology/keq233. Epub 2010 Aug 4.
Zotero 插件